StrokePub Date : 2026-11-13DOI: 10.1161/STROKEAHA.125.053981
Mukul Sharma, Lizhen Xu, John W Eikelboom, Alexander T Cohen, Andrew M Demchuk, Anna Członkowska, Arne G Lindgren, Carlos A Molina, Daniel Bereczki, Danilo Toni, David J Seiffge, David Tanne, Else Charlotte Sandset, Georgios Tsivgoulis, Hanne Christensen, Jan Beyer-Westendorf, Jonathan M Coutinho, Mark Crowther, Peter Verhamme, Pierre Amarenco, Risto O Roine, Robert Mikulik, Robin Lemmens, Roland Veltkamp, Saskia Middeldorp, Truman John Milling, Sven Poli, C Michael Gibson, Deborah M Siegal, Mikael Knutsson, Cecilia Falkenberg, Rohit Narayan, Raisa Kurlyandskaya, Per Ladenvall, Ashkan Shoamanesh
{"title":"Predictors of Thrombotic Events and Mortality in Patients Treated With Andexanet: A Pooled Analysis.","authors":"Mukul Sharma, Lizhen Xu, John W Eikelboom, Alexander T Cohen, Andrew M Demchuk, Anna Członkowska, Arne G Lindgren, Carlos A Molina, Daniel Bereczki, Danilo Toni, David J Seiffge, David Tanne, Else Charlotte Sandset, Georgios Tsivgoulis, Hanne Christensen, Jan Beyer-Westendorf, Jonathan M Coutinho, Mark Crowther, Peter Verhamme, Pierre Amarenco, Risto O Roine, Robert Mikulik, Robin Lemmens, Roland Veltkamp, Saskia Middeldorp, Truman John Milling, Sven Poli, C Michael Gibson, Deborah M Siegal, Mikael Knutsson, Cecilia Falkenberg, Rohit Narayan, Raisa Kurlyandskaya, Per Ladenvall, Ashkan Shoamanesh","doi":"10.1161/STROKEAHA.125.053981","DOIUrl":"https://doi.org/10.1161/STROKEAHA.125.053981","url":null,"abstract":"<p><strong>Background: </strong>Andexanet reduces hematoma expansion compared with usual care for acute FXa (factor Xa) inhibitor-associated intracerebral hemorrhage but is associated with a risk of thrombotic events (TE). We pooled data from andexanet-treated trial participants to determine baseline predictors of TE.</p><p><strong>Methods: </strong>Secondary analyses of andexanet-treated participants in ANNEXA-I (Andexanet Alfa, a Novel Antidote to the Anticoagulant Effects of Factor Xa Inhibitors in ICH) and ANNEXA-4 (Andexanet Alfa, a Novel Antidote to the Anticoagulation Effects of Factor Xa Inhibitors), which included adults with acute life-threatening hemorrhage on FXa inhibitors. Stratified Cox proportional hazards models were used to examine associations between baseline variables and arterial or all TE and mortality. A stratified Cox regression model with arterial events as time-dependent covariates was used to examine associations of arterial events with mortality, adjusted for clinical covariates.</p><p><strong>Results: </strong>Of 741 participants (mean age, 78.5 years; 54.5% male), 593 (80.0%) had intracranial hemorrhage and 109 (14.7%) had gastrointestinal hemorrhage. Seventy-seven (10.4%) participants had ≥1 TE, and 147 (19.8%) died. Arterial and venous thromboembolism events occurred a median of 3.5 days (interquartile range, 2.0-12.0) and 14.0 days (interquartile range, 10.0-20.0), respectively, after randomization. No baseline factors were associated with all TE. Arterial TE were associated with prior myocardial infarction (hazard ratio [HR], 2.64 [95% CI, 1.33-5.26]), high-dose eligibility (HR, 2.44 [95% CI, 1.33-4.48]), female sex (HR, 1.78 [95% CI, 1.00-3.16]), and age (HR per year, 1.04 [95% CI, 1.00-1.08]). Mortality was associated with arterial TE (HR, 2.68 [95% CI, 1.64-4.36]), prior congestive heart failure (HR, 2.53 [95% CI, 1.76-3.63]), intracerebral hemorrhage or intraventricular hemorrhage (HR, 1.90 [95% CI, 1.20-3.01]), and age (HR per year, 1.06 [95% CI, 1.03-1.08]). The initiation of anticoagulation after randomization was associated with a reduction in TE.</p><p><strong>Conclusions: </strong>In FXa inhibitor-associated hemorrhage treated with andexanet, baseline factors are associated with arterial TE and can be used to inform treatment decisions. Initiation of anticoagulation reduces the occurrence of TE.</p><p><strong>Registration: </strong>URL: https://www.clinicaltrials.gov; Unique identifier: NCT02313909. URL: https://www.clinicaltrials.gov; Unique identifier: NCT02329327.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149410906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Efficacy of Repetitive Transcranial Magnetic Stimulation in Preventing Poststroke Spasticity: A Sham-Controlled Trial.","authors":"Venkata Divya Mupparaju, Sanjeev Kumar Bhoi, Menka Jha, Priyanka Samal, Suprava Naik","doi":"10.1161/STROKEAHA.126.055772","DOIUrl":"https://doi.org/10.1161/STROKEAHA.126.055772","url":null,"abstract":"<p><strong>Background: </strong>Poststroke spasticity significantly impairs recovery, yet preventive strategies remain limited. This study evaluated the effectiveness of repetitive transcranial magnetic stimulation (rTMS) in reducing the development and severity of spasticity in patients with early subacute stroke, offering a possible early intervention.</p><p><strong>Methods: </strong>In this double-blind, randomized, sham-controlled trial, 70 patients with early subacute stroke (7-30 days) were randomized to receive 3 sessions of low-frequency (1 Hz, 1000 pulses at 90% resting motor threshold) rTMS over contralesional primary motor cortex (n=35) or sham stimulation (n=35), alongside standard care. The primary outcome was upper-limb spasticity assessed using the modified Modified Ashworth Scale. Secondary outcomes included handgrip strength, muscle power assessed by the Medical Research Council scale, pain assessed by the Visual Analogue Scale, modified Rankin Scale, and Stroke Impact Scale 3.0.</p><p><strong>Results: </strong>rTMS therapy significantly lowered spasticity scores at 1 and 3 months across all assessed upper-limb joints (<i>P</i>=0.001), improved handgrip strength (<i>P</i>=0.01), and prevented pain (<i>P</i>=0.001). Stroke Impact Scale scores at 1 month showed greater gains in activities of daily living, mobility, hand function, social participation, and recovery in the rTMS group (<i>P</i>=0.001). Functional independence (modified Rankin Scale) was significantly better in the rTMS group (<i>P</i>=0.006) at 3 months. On binary logistic regression, sham stimulation was associated with greater odds of developing spasticity at 1 month (shoulder odds ratio [OR], 8.29 [95% CI, 1.95-35.27], <i>P</i>=0.04; elbow OR, 7.62 [95% CI, 1.69-34.35], <i>P</i>=0.08; wrist OR, 5.18 [95% CI, 1.60-16.78], <i>P</i>=0.06). At 3 months, sham stimulation remained predictive, with higher odds of spasticity at the shoulder (OR, 15.3 [95% CI, 8.26-28.43]), elbow (OR, 13.43 [95% CI, 3.94-45.78]), wrist (OR, 19.9 [95% CI, 4.9-80.96]), and fingers (OR, 26.25 [95% CI, 5.19-132.87], all <i>P</i>=0.001). Minor adverse events like headache and light-headedness were observed in 5 patients.</p><p><strong>Conclusions: </strong>Low-frequency rTMS over contralesional primary motor cortex significantly prevented spasticity, improved motor recovery, reduced pain, improved functional outcomes and quality of life in early subacute stroke, supporting its role as a promising adjunctive therapy in early stroke rehabilitation.</p><p><strong>Registration: </strong>URL: https://ctri.nic.in/; Unique identifier: CTRI/2024/01/061225.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-12DOI: 10.1161/STROKEAHA.126.056543
Alexandre Bani-Sadr, Philippine Roy, Marc Hermier, Andrea Gambino, Charles de Bourguignon, Morgane Laubacher, Roberta Cao, Paul Clottes, Elodie Ong, Laurent Derex, Laura Mechtouff, Norbert Nighoghossian, Tae-Hee Cho, Roberto Riva, Carole Frindel, Yves Berthezene
{"title":"Mapping the Metabolic Penumbra From Standard CT Perfusion: CTP-Derived CMRO<sub>2</sub>/OEF Estimates Versus CBF/Tmax.","authors":"Alexandre Bani-Sadr, Philippine Roy, Marc Hermier, Andrea Gambino, Charles de Bourguignon, Morgane Laubacher, Roberta Cao, Paul Clottes, Elodie Ong, Laurent Derex, Laura Mechtouff, Norbert Nighoghossian, Tae-Hee Cho, Roberto Riva, Carole Frindel, Yves Berthezene","doi":"10.1161/STROKEAHA.126.056543","DOIUrl":"https://doi.org/10.1161/STROKEAHA.126.056543","url":null,"abstract":"<p><strong>Background: </strong>CT perfusion (CTP) hemodynamic thresholds may overestimate the ischemic core (ghost core) in early presenters. We hypothesized that a metabolic model, defining the core by decreased cerebral metabolic rate of oxygen and penumbra by increased oxygen extraction fraction, estimated from standard CTP, would better predict tissue fate and early neurological outcome.</p><p><strong>Methods: </strong>This retrospective single-center study (October 2015 to October 2025) included consecutive thrombectomy-treated patients with anterior-circulation large-vessel occlusion, admission CTP, and 48±12-hour diffusion-weighted imaging. Predefined relative cerebral metabolic rate of oxygen and oxygen extraction fraction thresholds (metabolic model) were compared with relative cerebral blood flow ≤30% and time-to-maximum (Tmax) ≥6 seconds (hemodynamic model) against diffusion-weighted imaging. Each imaging model (core and penumbra volumes) was added to clinical covariates predicting 48-hour lesion volume (linear regression) and 24-hour and discharge National Institutes of Health Stroke Scale (ANCOVA), tested by nested <i>F</i>-tests; imaging models were compared by paired bootstrap of cross-validated R<sup>2</sup>.</p><p><strong>Results: </strong>Of 3011 thrombectomy patients, 227 were included (median age, 70 years; 46% male; median onset-to-CTP, 108 minutes; 162 recanalized). Relative cerebral metabolic rate of oxygen ≤30% reduced core overestimation versus relative cerebral blood flow ≤30% (bias, +2.6 versus +20.0 mL; dice, 0.20 versus 0.18; both <i>P</i><0.001; reproduced in temporal validation), but >10-mL underestimation was more frequent (17% versus 6%). Relative cerebral blood flow error decreased with onset-to-recanalization delay (ρ=-0.30), unlike relative cerebral metabolic rate of oxygen (ρ=0.01). In 65 nonrecanalized patients, relative oxygen extraction fraction ≥125% outperformed time-to-maximum on bias (+14.3 versus +19.3 mL; <i>P</i><0.001) and dice (<i>P</i>=0.002), but not absolute error (<i>P</i>=0.24). The metabolic model better explained 48-hour lesion volume (cross-validated R<sup>2</sup>, 0.32 versus 0.22; <i>P</i>=0.002). Only the metabolic model improved 24-hour (<i>P</i>=0.004) and discharge (<i>P</i>=0.009) National Institutes of Health Stroke Scale score prediction over clinical covariates, outperforming the hemodynamic model at discharge (<i>P</i>=0.04) but not at 24 hours (<i>P</i>=0.21).</p><p><strong>Conclusions: </strong>A CTP-derived metabolic model reduced ghost-core misclassification, particularly in early presenters, and better explained 48-hour lesion volume than hemodynamic thresholds, with modest added value for early neurological outcome. Positron emission tomography and external validation are warranted.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-12DOI: 10.1161/STROKEAHA.125.053518
Wendy Wang, Yinxiang Wu, Rizwan Kalani, Ting Ye, Traci M Bartz, Michael J Zhang, James S Pankow, Kamakshi Lakshminarayan, Alvaro Alonso, Pamela L Lutsey, Christie M Ballantyne, Kunihiro Matsushita, Michelle C Johansen, Rebecca F Gottesman, Josef Coresh, Wei Pan, Keenan A Walker, Susan R Heckbert, Bruce M Psaty, Colleen M Sitlani, Jennifer A Brody, Nancy Finkel, Valborg Gudmundsdottir, Vilmundur Gudnason, W T Longstreth, Lin Yee Chen, James S Floyd
{"title":"Proteomics and Risk of Incident Ischemic Stroke: Meta-Analysis of the ARIC Study and CHS.","authors":"Wendy Wang, Yinxiang Wu, Rizwan Kalani, Ting Ye, Traci M Bartz, Michael J Zhang, James S Pankow, Kamakshi Lakshminarayan, Alvaro Alonso, Pamela L Lutsey, Christie M Ballantyne, Kunihiro Matsushita, Michelle C Johansen, Rebecca F Gottesman, Josef Coresh, Wei Pan, Keenan A Walker, Susan R Heckbert, Bruce M Psaty, Colleen M Sitlani, Jennifer A Brody, Nancy Finkel, Valborg Gudmundsdottir, Vilmundur Gudnason, W T Longstreth, Lin Yee Chen, James S Floyd","doi":"10.1161/STROKEAHA.125.053518","DOIUrl":"https://doi.org/10.1161/STROKEAHA.125.053518","url":null,"abstract":"<p><strong>Background: </strong>Ischemic stroke preventive therapies have been slow to emerge due to a limited understanding of the underlying molecular mechanisms. We aimed to discover new protein risk factors that are potential etiologic factors and may be candidates for therapeutic intervention.</p><p><strong>Methods: </strong>We included ARIC study (Atherosclerosis Risk in Communities) and CHS (Cardiovascular Health Study) participants without prevalent stroke at the time of proteomic profiling (1990-1992 in ARIC and 1992-1993 in CHS). Relative concentrations of proteins in blood were assessed with aptamers (n=4954). Ischemic stroke events were adjudicated through 2019 in ARIC and 2015 in CHS. Study-specific Cox regression adjusting for ischemic stroke risk factors was used to estimate associations between proteins and incident ischemic stroke. Study-specific estimates were combined using fixed-effects meta-analysis. Replication was conducted in 2 independent cohorts (AGES-Reykjavik, UK Biobank). Proteins with a false discovery rate <i>q</i> value <0.05 were considered replicated. Mendelian randomization analyses assessed for potential causal associations between proteins and ischemic stroke.</p><p><strong>Results: </strong>Median follow-up was 25 and 12 years in ARIC and CHS. 1397 out of 14 139 (10%) participants experienced an ischemic stroke. 44 proteins were significantly associated with ischemic stroke risk (<i>P</i><1.0×10<sup>-5</sup>), of which 26 are novel. In 2 independent cohorts, 37 (84%) associations were directionally concordant, and 26 (59%) met criteria for replication. Mendelian randomization analyses suggested MMP12 (matrix metallopeptidase-12) and CNTN1 (contactin-1) may be causally related to ischemic stroke risk. In multivariable Mendelian randomization analyses, higher MMP12 levels had a direct protective effect on ischemic stroke risk, while CNTN1 had a direct harmful effect.</p><p><strong>Conclusions: </strong>This proteomic and genomic investigation of ischemic stroke identified novel risk biomarkers and 2 potential etiologic CNTN1 factors that are regulated in response to atherosclerosis and obesity. If future studies confirm our findings, these results may have implications for the development of new preventive therapies.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149395285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-09DOI: 10.1161/STROKEAHA.126.056058
Tu Q Nguyen, Tim Spelman, Lachlan L Dalli, Eric Zhao, Benjamin D Atkins, Aaron L Weinman, Hazel J Clothier, Suzanne Mavoa, Monique F Kilkenny, Christopher M Reid, Jim P Buttery
{"title":"Stroke Triggered by Respiratory Viruses: Ecological Study of Temporal and Spatiotemporal Associations.","authors":"Tu Q Nguyen, Tim Spelman, Lachlan L Dalli, Eric Zhao, Benjamin D Atkins, Aaron L Weinman, Hazel J Clothier, Suzanne Mavoa, Monique F Kilkenny, Christopher M Reid, Jim P Buttery","doi":"10.1161/STROKEAHA.126.056058","DOIUrl":"https://doi.org/10.1161/STROKEAHA.126.056058","url":null,"abstract":"<p><strong>Background: </strong>Infections have been linked as short-term triggers for stroke, but the extent of their contribution is unclear. We examined population-level temporal and spatiotemporal associations between common respiratory viruses and stroke in an ecological study in Victoria, Australia.</p><p><strong>Methods: </strong>The statewide Victorian Admitted Episodes data set, covering all hospital admissions for stroke between June 2010 and December 2022, was analyzed against statewide representative data from SnotWatch respiratory polymerase chain reaction tests. Population size, climate, and air pollution data sets for the same period were treated as population-level confounders. Time-series analysis was used to model weekly stroke events and respiratory virus levels (% of polymerase chain reaction tests positive for each pathogen), and attributable fractions were computed using distributed lag nonlinear modeling. To examine spatiotemporal variation, the weekly association by Statistical Area Level 2 was modeled using a Bayesian Integrated Nested Laplace Approximation.</p><p><strong>Results: </strong>We analyzed 153 730 stroke events (61% ischemic, 25% hemorrhagic, and 14% unspecified) and 6 180 896 respiratory specimens. In the time-series analysis, higher weekly levels of specific respiratory viruses were associated with increased rates of stroke after controlling for confounders. Our model estimated that the fractions of strokes attributed to enterovirus and human metapneumovirus 4.6% (95% CI, 2.5-6.6) and 1.3% (95% CI, 0.3-2.3), respectively, which rose during peak viral weeks. The attributable fractions differed between ischemic stroke (human metapneumovirus 3.7%) and hemorrhagic stroke (enterovirus, 5.8%; parainfluenza, 3.2%). Spatiotemporal analysis revealed greater effect sizes in areas potentially associated with agricultural/industrial activity, as well as in outer-urban areas, based on the regionality of the Statistical Area Level 2 of usual patient residence.</p><p><strong>Conclusions: </strong>At the population level, there were clear, observable time- and space-time-related associations between respiratory virus activity and stroke. People living in higher-risk areas during peak respiratory virus periods may be more susceptible to acute stroke. This warrants further investigation.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149380624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-06DOI: 10.1161/STROKEAHA.126.051399
Hugh Markus
{"title":"How Stroke Genetics Is Impacting Clinical Care: Now and the Future.","authors":"Hugh Markus","doi":"10.1161/STROKEAHA.126.051399","DOIUrl":"https://doi.org/10.1161/STROKEAHA.126.051399","url":null,"abstract":"<p><p>The past decade has seen a transformation in our understanding of the genetics of stroke. However, a commonly asked question is how do these advances impact the practicing clinician now, and what are their implications for clinical care in the future? This review outlines the major recent advances in stroke genetics and addresses 4 questions most relevant to the clinician: What do we now know about the genetic architecture of stroke? When and how should genetic testing be used to identify monogenic stroke? How can genetic information be applied to risk stratification and prevention? And what therapeutic implications are emerging from genetic discoveries? It highlights the success of genome-wide association studies in stroke and how these have transformed how we understand the genetic architecture of stroke. An increasing number of monogenic forms of cerebral small vessel disease are being identified, and guidance on when and how to test for them is covered. Polygenic risk scores are gaining increasing attention. How these can be applied, and the challenges in their use are discussed. Lastly, the impact of genomics on stroke therapeutics, whether by identifying new targets, assessing causality using techniques such as Mendelian randomization, or pharmacogenomics, is discussed.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149343534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Physical Activity Associated With Early Independent Walking in Nonambulatory Patients With Subacute Stroke.","authors":"Natsuki Shimizu, Tomoya Ishigaki, Yosuke Kimura, Hiroki Kubo, Takumi Kai, Yoshiki Suzuki, Shu Tanaka, Keishi Yoshida, Mutsuo Takeuchi, Sota Kobayashi, Seiya Yamamoto, Kouhei Moronaga, Tomohiro Yoshimura, Masashi Kanai","doi":"10.1161/STROKEAHA.126.056467","DOIUrl":"https://doi.org/10.1161/STROKEAHA.126.056467","url":null,"abstract":"<p><strong>Background: </strong>Identifying the intensity and frequency of physical activity associated with early independent walking in nonambulatory patients with subacute stroke may inform daily physical activity promotion during hospitalization, which was the aim of the present study.</p><p><strong>Methods: </strong>This multicenter prospective cohort study was conducted at 11 facilities. Baseline was defined as admission to a subacute rehabilitation ward, with subacute referring to the phase after completion of acute stroke treatment. Patients with subacute stroke and a Functional Ambulation Category of 1 to 2 at admission were included. Physical activity was measured using an accelerometer for 1 week at baseline. The outcome was achievement of independent walking at 1 month from baseline (Functional Ambulation Category ≥4). To examine the intensity of physical activity associated with the outcome, modified Poisson regression was used to evaluate time spent in low -intensity physical activity (LPA; low-LPA, 1.6-1.9 metabolic equivalents [METs]), high-LPA (2.0-2.9 METs), and moderate-to-vigorous intensity physical activity (≥3.0 METs). Furthermore, to assess frequency associated with activity intensity, bouts of physical activity at or above the intensity level (≥1.6, ≥2.0, or ≥3.0 METs) were calculated as short-bouts (≥5 to <10 minutes) and long-bouts (≥10 minutes), and their associations with the outcome were examined.</p><p><strong>Results: </strong>Of 389 participants (mean age, 68.1 years; 45.0% female), 113 achieved independent walking during follow-up. Time spent in high-LPA was associated with independent walking when expressed per 5 min/d (risk ratio, 1.067 [95% CI, 1.010-1.131]), whereas low-LPA and moderate-to-vigorous intensity physical activity were not. The number of short-bouts at ≥2.0 METs was associated with independent walking (risk ratio, 1.208 [95% CI, 1.060-1.375]), whereas long-bouts were not relevant.</p><p><strong>Conclusions: </strong>Accumulation of high-LPA and short-bouts at ≥2.0 METs was associated with early independent walking. These findings may help characterize activity intensity and bout frequency associated with walking independence in nonambulatory patients with subacute stroke during inpatient rehabilitation.</p><p><strong>Registration: </strong>URL: https://www.umin.ac.jp/ctr; Unique identifier: UMIN000058526.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-03DOI: 10.1161/STROKEAHA.126.055838
Jin Vivian Lee, Anna L Huguenard, Ralph G Dacey, Joshua W Osbun
{"title":"Preprocedural Curvature Assessment Can Stratify Recanalization Risk Before Device Selection in Mechanical Thrombectomy.","authors":"Jin Vivian Lee, Anna L Huguenard, Ralph G Dacey, Joshua W Osbun","doi":"10.1161/STROKEAHA.126.055838","DOIUrl":"10.1161/STROKEAHA.126.055838","url":null,"abstract":"<p><strong>Background: </strong>Vascular geometry may impede catheter navigation during mechanical thrombectomy. We evaluated whether cervical curvature predicts recanalization success.</p><p><strong>Methods: </strong>This is a retrospective single-center cohort of 160 anterior large vessel occlusion patients treated with mechanical thrombectomy at a comprehensive stroke center (Barnes-Jewish Hospital/Washington University School of Medicine, St. Louis, MO) from May 2019 to February 2021. Cervical curvature was computed using 3-dimensional vessel centerlines derived from preprocedural computed tomography angiography. Primary outcomes were successful recanalization (final modified Thrombolysis in Cerebral Infarction score ≥2b) and intracranial access time (puncture→first pass). Associations were evaluated with multivariable linear or logistic regression, adjusting for age, National Institutes of Health Stroke Scale, first-line device, and access route. Random Forest and Gradient Boosting models with Gini Importance and Shapley Additive Explanation explained feature importance.</p><p><strong>Results: </strong>Mean age was 67±15 years; median National Institutes of Health Stroke Scale 16; mean total curvature was 9.80±2.85. Median intracranial access time was 24 minutes (interquartile range, 17-32), with no correlation to cervical curvature (ρ=0.054; adjusted β=0.20 min/unit [95% CI, -0.75, 1.15]; <i>P</i>=0.676). Successful recanalization occurred in 86% and varied across curvature tertiles (low 91%, mid 93%, high 75%; <i>P</i>=0.017). Per-unit curvature increase was associated with recanalization failure (adjusted odds ratio, 1.21 [95% CI, 1.02-1.43]; <i>P</i>=0.028). Receiver operating characteristic-derived curvature threshold (>11.54) identified a high-risk group (adjusted odds ratio, 5.10 [95% CI, 1.88-13.84]; <i>P</i>=0.001). Machine learning confirmed cervical curvature as the dominant predictor, with a Shapley Additive Explanation peak effect at 11.65.</p><p><strong>Conclusions: </strong>Cervical curvature independently predicts mechanical thrombectomy recanalization failure, with a threshold effect near 11.6 units. Preprocedural curvature assessment derived from routine computed tomography angiography may improve risk stratification and inform mechanical thrombectomy strategy.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-03DOI: 10.1161/STROKEAHA.126.056786
Lorenzo Nucci, Fabrizio Vecchio, Serena Polidoro, Francesco Iodice, Simone Criscuolo, Debora Gabbani, Carrie-Louise Thouant, Cristiano Pecchioli, Irene Insogna, Carmen De Caro, Laura Titti, Giorgio Felzani, Domenica Le Pera, Paolo Maria Rossini
{"title":"Motor Response Variability Reflects Recovery Potential After Stroke: A Transcranial Magnetic Stimulation Study.","authors":"Lorenzo Nucci, Fabrizio Vecchio, Serena Polidoro, Francesco Iodice, Simone Criscuolo, Debora Gabbani, Carrie-Louise Thouant, Cristiano Pecchioli, Irene Insogna, Carmen De Caro, Laura Titti, Giorgio Felzani, Domenica Le Pera, Paolo Maria Rossini","doi":"10.1161/STROKEAHA.126.056786","DOIUrl":"https://doi.org/10.1161/STROKEAHA.126.056786","url":null,"abstract":"<p><strong>Background: </strong>Stroke recovery is highly heterogeneous, and predictive neurophysiological markers of motor outcome are still needed. Although transcranial magnetic stimulation-derived motor evoked potentials (MEPs) are widely used to assess corticospinal integrity, their trial-to-trial variability remains poorly explored and has largely been interpreted as noise rather than a source of clinically relevant information.</p><p><strong>Methods: </strong>In this prospective longitudinal observational study, we investigated MEP peak-to-peak amplitude and amplitude variability in 77 patients with subacute stroke assessed at baseline (T0, early subacute phase) and after a 2-month high-intensity daily rehabilitation program (T1), alongside 10 age- and sex-matched healthy controls. MEPs were recorded from both hemispheres at rest. Clinical outcomes were evaluated using the Fugl-Meyer Upper Extremity scale and a Motor Recovery Index.</p><p><strong>Results: </strong>Seventy-seven patients with subacute stroke (mean age, 68.5±12.7 years; 41.6% women) and 10 age- and sex-matched healthy controls (mean age, 73.9±4.3 years; 40.0% women) were included. At T0, MEP amplitude was lower in the affected than in the unaffected hemisphere (0.16±0.02 versus 0.38±0.01 mV; <i>P</i>=5.42×10<sup>-10</sup>), as was MEP variance (0.013±0.002 versus 0.038±0.003 mV<sup>2</sup>; <i>P</i>=8.43×10<sup>-</sup><sup>12</sup>). Regarding T1, MEP amplitude increased over time in the affected hemisphere (0.21±0.02 mV; <i>P</i>=0.01), whereas MEP variance remained unchanged (<i>P</i>=0.55). Importantly, baseline MEP amplitude was strongly associated with motor status at follow-up (Fugl-Meyer Upper Extremity scale at T1; <i>P</i>=9.52×10<sup>-</sup><sup>9</sup>), but not with the degree of recovery. In contrast, baseline MEP variability was significantly associated with both motor outcome (Fugl-Meyer Upper Extremity scale at T1; <i>P</i>=2.76×10<sup>-</sup><sup>7</sup>) and the Motor Recovery Index (<i>P</i>=0.009), indicating a specific link with recovery potential.</p><p><strong>Conclusions: </strong>These findings reveal a dissociation between MEP amplitude and variability, suggesting that they capture complementary aspects of corticospinal function. Although amplitude reflects the current functional state of motor pathways, variability appears to index network flexibility and adaptive capacity. MEP variability may, therefore, represent a novel neurophysiological biomarker for predicting motor recovery and guiding personalized rehabilitation strategies after stroke.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":""},"PeriodicalIF":11.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149324723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
StrokePub Date : 2026-11-01Epub Date: 2026-09-10DOI: 10.1161/STROKEAHA.126.055755
Abdulaziz T Bako, Elizabeth F Larkin, Thomas B H Potter, Alan P Pan, Farhaan S Vahidy
{"title":"Inpatient Rehabilitation and Major Adverse Cardiovascular Events After Ischemic Stroke.","authors":"Abdulaziz T Bako, Elizabeth F Larkin, Thomas B H Potter, Alan P Pan, Farhaan S Vahidy","doi":"10.1161/STROKEAHA.126.055755","DOIUrl":"10.1161/STROKEAHA.126.055755","url":null,"abstract":"<p><strong>Background: </strong>Acute ischemic stroke (AIS) survivors are at high risk of major adverse cardiovascular events (MACE), highlighting the need to identify modifiable secondary prevention targets. We assessed whether postacute discharge destination is associated with 1-year MACE risk among AIS survivors.</p><p><strong>Methods: </strong>In this retrospective cohort study, adult AIS survivors were identified from the state inpatient and emergency department databases of 5 US states (2016-2019) and categorized by discharge destination: home, inpatient rehabilitation facility (IRF), or skilled nursing facility (SNF). Other destinations were excluded. The primary outcome was 1-year MACE, defined as recurrent stroke, acute myocardial infarction, systemic embolism, or vascular death. Multivariable Cox models, adjusted for demographic and clinical factors, were used to evaluate the association between discharge disposition and MACE risk. Fine-Gray models were used for nonfatal secondary outcomes, and restricted mean survival time analyses were used to estimate absolute risk. Effect modification by age (<65 versus ≥65 years) was examined. Confounder-adjusted number-needed-to-be-exposed was estimated by marginal standardization.</p><p><strong>Results: </strong>Among 213 511 AIS survivors (median age, 71 years), 16 237 (7.6%) experienced MACE within 1-year. MACE incidence was lowest after IRF discharge (6.6%) versus home (7.6%) or SNF (8.3%). In adjusted analyses, IRF discharge was associated with lower MACE risk versus home (adjusted hazard ratio, 0.88 [95% CI, 0.83-0.93]) and SNF (0.84 [95% CI, 0.79-0.89]). The association persisted across age strata but was more pronounced in patients <65 years (<i>P</i><sub>interaction</sub>=0.014). Restricted mean survival time analyses indicated that IRF discharge was associated with 3.47 and 3.87 additional MACE-free days versus home and SNF discharge, respectively (both <i>P</i><0.001). Adjusted number-needed-to-be-exposed were 115 (95% CI, 80-207) for IRF versus home and 87 (95% CI, 64-136) for IRF versus SNF.</p><p><strong>Conclusions: </strong>Postacute IRF discharge is associated with a lower 1-year MACE risk after AIS, highlighting the postacute care setting as a potentially modifiable system-level target for secondary prevention of long-term vascular outcomes.</p>","PeriodicalId":21989,"journal":{"name":"Stroke","volume":" ","pages":"3372-3384"},"PeriodicalIF":11.1,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148919995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}